Cargando…
Effective Dose Range of Intrathecal Isobaric Bupivacaine to Achieve T5–T10 Sensory Block Heights for Elderly and Overweight Patients: An Observational Study
Background and Objectives: The dose selection for isobaric bupivacaine determines the success of spinal anesthesia (SA). A dose higher than the optimal dose causes high SA, whereas an underdose leads to inadequate spread of cephalad. As it involves anatomical and physiological alterations, the dosin...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10057130/ https://www.ncbi.nlm.nih.gov/pubmed/36984485 http://dx.doi.org/10.3390/medicina59030484 |
_version_ | 1785016286704566272 |
---|---|
author | Visavakul, Ornwara Leurcharusmee, Prangmalee Pipanmekaporn, Tanyong Khorana, Jiraporn Patumanond, Jayanton Phinyo, Phichayut |
author_facet | Visavakul, Ornwara Leurcharusmee, Prangmalee Pipanmekaporn, Tanyong Khorana, Jiraporn Patumanond, Jayanton Phinyo, Phichayut |
author_sort | Visavakul, Ornwara |
collection | PubMed |
description | Background and Objectives: The dose selection for isobaric bupivacaine determines the success of spinal anesthesia (SA). A dose higher than the optimal dose causes high SA, whereas an underdose leads to inadequate spread of cephalad. As it involves anatomical and physiological alterations, the dosing should be reduced with advancing age and body mass index values. Therefore, this study aimed to demonstrate the association between the isobaric bupivacaine dose and block height, and to determine the dose intervals of bupivacaine to achieve the T5–T10 sensory block with a low probability of high SA in elderly and overweight patients. Material and Methods: This retrospective observational study recruited 1079 adult patients who underwent SA with 0.5% isobaric bupivacaine from 2018 to 2021. The patients were divided into four categories: category 1 (age < 60, BMI < 25), category 2 (age < 60, BMI ≥ 25), category 3 (age ≥ 60, BMI < 25), and category 4 (age ≥ 60, BMI ≥ 25). The bupivacaine dose and sensory block height (classified into three levels: high (T1–T4), favorable (T5–T10), and low (T11–L2)) were recorded. Results: The sensory block level increased significantly with increasing doses of bupivacaine for patients in categories 1 and 2. The suggested dose ranges for the favorable block heights were 15–17 and 10.5–16 mg in patient categories 1–2 and 3–4, respectively. In these dose ranges, the probability range of high SA was 10–15%. Conclusions: The sensory block height following SA was associated with the bupivacaine dose in patients aged <60 years. Regardless of the BMI, the suggested dose ranges of 0.5% isobaric bupivacaine are 15–17 mg (3.0–3.4 mL) and 10.5–16 mg (2.1–3.2 mL) for patients aged <60 and ≥60 years, respectively. |
format | Online Article Text |
id | pubmed-10057130 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-100571302023-03-30 Effective Dose Range of Intrathecal Isobaric Bupivacaine to Achieve T5–T10 Sensory Block Heights for Elderly and Overweight Patients: An Observational Study Visavakul, Ornwara Leurcharusmee, Prangmalee Pipanmekaporn, Tanyong Khorana, Jiraporn Patumanond, Jayanton Phinyo, Phichayut Medicina (Kaunas) Article Background and Objectives: The dose selection for isobaric bupivacaine determines the success of spinal anesthesia (SA). A dose higher than the optimal dose causes high SA, whereas an underdose leads to inadequate spread of cephalad. As it involves anatomical and physiological alterations, the dosing should be reduced with advancing age and body mass index values. Therefore, this study aimed to demonstrate the association between the isobaric bupivacaine dose and block height, and to determine the dose intervals of bupivacaine to achieve the T5–T10 sensory block with a low probability of high SA in elderly and overweight patients. Material and Methods: This retrospective observational study recruited 1079 adult patients who underwent SA with 0.5% isobaric bupivacaine from 2018 to 2021. The patients were divided into four categories: category 1 (age < 60, BMI < 25), category 2 (age < 60, BMI ≥ 25), category 3 (age ≥ 60, BMI < 25), and category 4 (age ≥ 60, BMI ≥ 25). The bupivacaine dose and sensory block height (classified into three levels: high (T1–T4), favorable (T5–T10), and low (T11–L2)) were recorded. Results: The sensory block level increased significantly with increasing doses of bupivacaine for patients in categories 1 and 2. The suggested dose ranges for the favorable block heights were 15–17 and 10.5–16 mg in patient categories 1–2 and 3–4, respectively. In these dose ranges, the probability range of high SA was 10–15%. Conclusions: The sensory block height following SA was associated with the bupivacaine dose in patients aged <60 years. Regardless of the BMI, the suggested dose ranges of 0.5% isobaric bupivacaine are 15–17 mg (3.0–3.4 mL) and 10.5–16 mg (2.1–3.2 mL) for patients aged <60 and ≥60 years, respectively. MDPI 2023-03-01 /pmc/articles/PMC10057130/ /pubmed/36984485 http://dx.doi.org/10.3390/medicina59030484 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Visavakul, Ornwara Leurcharusmee, Prangmalee Pipanmekaporn, Tanyong Khorana, Jiraporn Patumanond, Jayanton Phinyo, Phichayut Effective Dose Range of Intrathecal Isobaric Bupivacaine to Achieve T5–T10 Sensory Block Heights for Elderly and Overweight Patients: An Observational Study |
title | Effective Dose Range of Intrathecal Isobaric Bupivacaine to Achieve T5–T10 Sensory Block Heights for Elderly and Overweight Patients: An Observational Study |
title_full | Effective Dose Range of Intrathecal Isobaric Bupivacaine to Achieve T5–T10 Sensory Block Heights for Elderly and Overweight Patients: An Observational Study |
title_fullStr | Effective Dose Range of Intrathecal Isobaric Bupivacaine to Achieve T5–T10 Sensory Block Heights for Elderly and Overweight Patients: An Observational Study |
title_full_unstemmed | Effective Dose Range of Intrathecal Isobaric Bupivacaine to Achieve T5–T10 Sensory Block Heights for Elderly and Overweight Patients: An Observational Study |
title_short | Effective Dose Range of Intrathecal Isobaric Bupivacaine to Achieve T5–T10 Sensory Block Heights for Elderly and Overweight Patients: An Observational Study |
title_sort | effective dose range of intrathecal isobaric bupivacaine to achieve t5–t10 sensory block heights for elderly and overweight patients: an observational study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10057130/ https://www.ncbi.nlm.nih.gov/pubmed/36984485 http://dx.doi.org/10.3390/medicina59030484 |
work_keys_str_mv | AT visavakulornwara effectivedoserangeofintrathecalisobaricbupivacainetoachievet5t10sensoryblockheightsforelderlyandoverweightpatientsanobservationalstudy AT leurcharusmeeprangmalee effectivedoserangeofintrathecalisobaricbupivacainetoachievet5t10sensoryblockheightsforelderlyandoverweightpatientsanobservationalstudy AT pipanmekaporntanyong effectivedoserangeofintrathecalisobaricbupivacainetoachievet5t10sensoryblockheightsforelderlyandoverweightpatientsanobservationalstudy AT khoranajiraporn effectivedoserangeofintrathecalisobaricbupivacainetoachievet5t10sensoryblockheightsforelderlyandoverweightpatientsanobservationalstudy AT patumanondjayanton effectivedoserangeofintrathecalisobaricbupivacainetoachievet5t10sensoryblockheightsforelderlyandoverweightpatientsanobservationalstudy AT phinyophichayut effectivedoserangeofintrathecalisobaricbupivacainetoachievet5t10sensoryblockheightsforelderlyandoverweightpatientsanobservationalstudy |